• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Prevalence of SARS-CoV-2 infection and impact of vaccination in dialysis patients over two years of the pandemic.

作者信息

Hitz Paolo, Pagnamenta Alberto, Pertusini Laura, Terrot Tatiana, Franzosi Yves, Bassi Jessica, Silacci-Fregni Chiara, Gaia Valeria, Martinetti Gladys, Keller Franco, Berwert Lorenzo, Ogna Valentina Forni, Lavorato-Hadjeres Soraya, Giunzioni Davide, D'Ermo Andrea, Valnegri Alan, Ferrari Paolo, Corti Davide, Ceschi Alessandro, Cippà Pietro, Piccoli Luca, Giannini Olivier

机构信息

Faculty of Biomedical Sciences, Università della Svizzera italiana, 6900, Lugano, Switzerland.

Clinical Trial Unit, Ente Ospedaliero Cantonale, 6900, Lugano, Switzerland.

出版信息

J Nephrol. 2023 Dec;36(9):2665-2667. doi: 10.1007/s40620-023-01754-1. Epub 2023 Sep 13.

DOI:10.1007/s40620-023-01754-1
PMID:37702913
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10703959/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e229/10703959/62f556d21a79/40620_2023_1754_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e229/10703959/62f556d21a79/40620_2023_1754_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e229/10703959/62f556d21a79/40620_2023_1754_Fig1_HTML.jpg

相似文献

1
Prevalence of SARS-CoV-2 infection and impact of vaccination in dialysis patients over two years of the pandemic.新冠疫情两年期间透析患者中新型冠状病毒2型感染的患病率及疫苗接种的影响
J Nephrol. 2023 Dec;36(9):2665-2667. doi: 10.1007/s40620-023-01754-1. Epub 2023 Sep 13.
2
COVID-19 in dialysis: clinical impact, immune response, prevention, and treatment.COVID-19 与透析：临床影响、免疫反应、预防和治疗。
Kidney Int. 2022 May;101(5):883-894. doi: 10.1016/j.kint.2022.01.022. Epub 2022 Feb 14.
3
Immunogenicity Rates After SARS-CoV-2 Vaccination in People With End-stage Kidney Disease: A Systematic Review and Meta-analysis.终末期肾病患者接种 SARS-CoV-2 疫苗后的免疫原性率：系统评价和荟萃分析。
JAMA Netw Open. 2021 Oct 1;4(10):e2131749. doi: 10.1001/jamanetworkopen.2021.31749.
4
Seroresponse to SARS-CoV-2 Vaccines among Maintenance Dialysis Patients over 6 Months.维持性透析患者接种 SARS-CoV-2 疫苗后 6 个月的血清学反应。
Clin J Am Soc Nephrol. 2022 Mar;17(3):403-413. doi: 10.2215/CJN.12250921. Epub 2022 Feb 10.
5
The representative COVID-19 cohort Munich (KoCo19): from the beginning of the pandemic to the Delta virus variant.代表 COVID-19 的慕尼黑队列（KoCo19）：从大流行开始到德尔塔病毒变异。
BMC Infect Dis. 2023 Jul 13;23(1):466. doi: 10.1186/s12879-023-08435-1.
6
Prevalence of SARS-CoV-2 antibodies among Belgian nursing home residents and staff during the primary COVID-19 vaccination campaign.在 COVID-19 疫苗接种运动初期，比利时养老院居民和工作人员中 SARS-CoV-2 抗体的流行情况。
Eur J Gen Pract. 2023 Dec;29(2):2149732. doi: 10.1080/13814788.2022.2149732. Epub 2022 Nov 28.
7
Prevalence of fatigue during the SARS-CoV-2 pandemic in patients and workers of a hemodialysis unit.血液透析单位患者及工作人员在新冠疫情期间疲劳的患病率
Med Clin (Barc). 2022 Sep 23;159(6):e37-e38. doi: 10.1016/j.medcli.2022.03.020. Epub 2022 May 31.
8
Immunogenicity of COVID-19 Tozinameran Vaccination in Patients on Chronic Dialysis.慢性透析患者 COVID-19 疫苗接种的免疫原性。
Front Immunol. 2021 Jun 30;12:690698. doi: 10.3389/fimmu.2021.690698. eCollection 2021.
9
SARS-CoV-2 in dialysis patients and the impact of vaccination.透析患者中的 SARS-CoV-2 与疫苗接种的影响。
BMC Nephrol. 2022 Sep 21;23(1):317. doi: 10.1186/s12882-022-02940-2.
10
Prevalence of COVID-19 Infection in Hemodialysis Patients Detected Using Serologic Screening.采用血清学筛查检测血液透析患者中新冠病毒感染的患病率
J Am Soc Nephrol. 2020 Dec;31(12):2966-2967. doi: 10.1681/ASN.2020081193. Epub 2020 Sep 29.

引用本文的文献

1
Increased breadth and neutralization of antibodies against SARS-CoV-2 variants after infection and vaccination: A serosurveillance study in pediatric patients of Southern Switzerland.感染和接种疫苗后对 SARS-CoV-2 变体的抗体的广度和中和能力增强：瑞士南部儿科患者的血清学监测研究。
Eur J Pediatr. 2024 Mar;183(3):1425-1434. doi: 10.1007/s00431-023-05400-7. Epub 2024 Jan 4.

本文引用的文献

1
Covid-19 Vaccines - Immunity, Variants, Boosters.新冠疫苗——免疫、变种、加强针
N Engl J Med. 2022 Sep 15;387(11):1011-1020. doi: 10.1056/NEJMra2206573. Epub 2022 Aug 31.
2
Severity of COVID-19 after Vaccination among Hemodialysis Patients: An Observational Cohort Study.接种疫苗后血液透析患者 COVID-19 严重程度的观察性队列研究。
Clin J Am Soc Nephrol. 2022 Jun;17(6):843-850. doi: 10.2215/CJN.16621221.
3
Incidence of severe breakthrough SARS-CoV-2 infections in vaccinated kidney transplant and haemodialysis patients.
接种疫苗的肾移植和血液透析患者中严重突破性 SARS-CoV-2 感染的发生率。
J Nephrol. 2022 Apr;35(3):769-778. doi: 10.1007/s40620-022-01257-5. Epub 2022 Feb 21.
4
Seroprevalence of the SARS-CoV-2 virus in the population of the southern Switzerland (Canton Ticino) - cohort study, results at 12 months.血清新型冠状病毒（SARS-CoV-2）在瑞士南部（提契诺州）人群中的流行率-队列研究，12 个月时的结果。
Swiss Med Wkly. 2021 Dec 28;151:w30116. doi: 10.4414/smw.2021.w30116. eCollection 2021 Dec 20.
5
The Global Impact of the COVID-19 Pandemic on In-Center Hemodialysis Services: An ISN-Dialysis Outcomes Practice Patterns Study Survey.2019冠状病毒病大流行对中心血液透析服务的全球影响：一项国际肾脏病学会-透析结果实践模式研究调查
Kidney Int Rep. 2022 Mar;7(3):397-409. doi: 10.1016/j.ekir.2021.12.011. Epub 2021 Dec 13.